| CTXR Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CTXR shares outstanding history going back to 6/9/2017:
Also see: CTXR Market Cap History CTXR YTD Return |
CTXR Shares Outstanding History — Citius Pharmaceuticals Share Count Over Time
As of 2/10/2026 Citius Pharmaceuticals has 22.38 million CTXR shares outstanding. Investors often track the CTXR shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CTXR share count trends over time, with 36 historical shares outstanding datapoints presented, dating back to 6/9/2017.
| CTXR Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CTXR Historical Shares Outstanding: +72.07% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CTXR Stock Price Chart |
| About Citius Pharmaceuticals Inc |
| Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. It develops and commercializes critical care products with a focus on oncology, anti-infectives in adjunct cancer care, prescription products and stem cell therapy. Its products include LYMPHIR, Mino-Lok, Halo-Lido, NoveCite and Mino-Wrap. LYMPHIR is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. We show 36 historical shares outstanding datapoints in our coverage of CTXR's shares outstanding history. Understanding the changing numbers of CTXR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CTXR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CTXR by allowing them to research CTXR shares outstanding history as well as any other stock in our coverage universe. |
| CTXR Current Stock Quote |
Quotes delayed 20 minutes  Free CTXR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CTXR Share Performance |
| Shares Outstanding Peers |
| Citius Pharmaceuticals (CTXR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CUE Shares Outstanding History CUR Shares Outstanding History CUTR Shares Outstanding History CVKD Shares Outstanding History CVRX Shares Outstanding History CVS Shares Outstanding History CWBR Shares Outstanding History CYCC Shares Outstanding History CYCN Shares Outstanding History CYH Shares Outstanding History More Healthcare companies » |
CTXR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
